Jupiter Neurosciences, Inc. (JUNS)
NASDAQ: JUNS · Real-Time Price · USD
0.3200
-0.0123 (-3.70%)
At close: May 19, 2026, 4:00 PM EDT
0.3301
+0.0101 (3.16%)
After-hours: May 19, 2026, 7:38 PM EDT

Jupiter Neurosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-9.18-8.64-2.44-4.78-4.96-4.2
Stock-Based Compensation
2.532.421.841.20.751.3
Other Adjustments
0.70.7-0.750.761.410.38
Change in Receivables
0-0---0.13
Changes in Inventories
0.01-0.16----
Changes in Accounts Payable
0.030.24-0.150.16-0.06-0.16
Changes in Accrued Expenses
0.460.02-02.181.550.85
Changes in Unearned Revenue
-00----
Changes in Other Operating Activities
-0.030.01-2.4100.06-0.04
Operating Cash Flow
-5.49-5.41-3.91-0.48-1.25-1.74
Long-Term Debt Issued
-5.580.140.390.980.53
Long-Term Debt Repaid
--0.15-2.36---
Net Long-Term Debt Issued (Repaid)
-5.43-2.220.390.980.53
Issuance of Common Stock
0.01-9.880.06-1.33
Net Common Stock Issued (Repurchased)
0.01-9.880.06-1.33
Financing Cash Flow
0.015.437.650.450.981.86
Net Cash Flow
-0.340.023.74-0.04-0.270.12
Free Cash Flow
-3.41-5.41-3.91-0.48-1.25-1.74
FCF Margin
--24838.20%---535.19%-
Free Cash Flow Per Share
-0.09-0.16-0.14-0.02-0.05-0.07
Levered Free Cash Flow
-8.7-3.1-7.23-2.05-2.43-3.6
Unlevered Free Cash Flow
-6.05-8.8-5.66-1.52-1.89-3.22
Updated May 14, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q